Bronislava Gedulin;Krystyna Tatarkiewicz;Denis Roy;David G. Parkes
发明人:
Krystyna Tatarkiewicz,David G. Parkes,Denis Roy,Bronislava Gedulin
申请号：
US13567932
公开号：
US20120295850A1
申请日:
2012.08.06
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The disclosure provides the use of GLP-1 receptor agonist compounds to treat pancreatitis (e.g., acute, chronic, hemorrhagic, necrotizing) in patients. The disclosure also provides the use of GLP-1 receptor agonist compounds to reduce elevated plasma amylase and/or lipase concentrations in patients. An exemplary GLP-1 receptor agonist compound is exenatide.
